Healthcare IT News November 12, 2021
The collaboration between the UAE capital’s Department of Health and Novartis will be dedicated to cardiovascular diseases – a leading cause of death in the Gulf nation.
Abu Dhabi’s Department of Health (DoH) has confirmed it has become the first healthcare regulator in the Middle East region – and the second in the world – to explore and adopt a Population Health Model (PHM). The model, which is being developed in collaboration with Switzerland’s Novartis, will be dedicated to cardiovascular diseases (CVDs), focusing on early detection, management, and prevention, the DoH announced.
“CVD is a major cause of death, hospitalisation, and low quality of life among patients. Therefore, it has become a key priority for the healthcare institutes in the...